2Sagar S,Nairn D,Stamatakis JD,et al.Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement[J].Lancet,1976,1 (7970):1151 -1154.
3Allaart CF,Poort SR,Rosendaal FR,et al.Increased risk of venous thrombosis m carriers of hereditary protein C deficiency defect[J].Lancet,1993,341 (8838):134-138.
4Dahlback B,Carlsson M,Svensson PJ.Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulation,in liver disease,and in disseminated intravascular coagulation[J].J Clin Invest,1988,81 (10):1445-1454.
5Griffin JH,Evatt B,Wideman C,et al.Anticoagulant protein C pathway defective in majority of thrombophilic patients [J].Blood,1993,82(7):1989-1993.
6Rosendaal FR,Koster T,Vandenbroucke JP,et al.High risk of thrombosis in patients homozygous for V Leiden( activated protein C resistance) [J].Blood,1995,85 (6):1504-1508.
7Koster T,Rosendaal FR,Deronde H,et al.Venous hrombosis due to poor anticoagulant response to activated proteiu C:Leiden thrombophilia study[ J].Lancet,1993,342 (8886):1503-1506.
8Den Heijer M,Blom H J,Gerrits WB,et al.Is hyperbomocystemaemia a risk factor for recurrent venous thrombosis [J] ? Lancet,1995,345 (8954):882-885.
9Poort SR,Rosendaal FR,Reitsma PH,et al.A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis [J].Blood,1996,88 (10):3698 -3703.
10Tollefsen DM.Laboratory diagnosis of antithrombin and heparin cofactor Ⅱ deficiency[J].Semin Thromb Hemost,1990,16 (2):162-168.
